You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
20 August 2026 - Pharmaceutical research services provider Charles River Laboratories International Inc (NYSE:CRL) and Medigen Vaccine Biologics Corp (MVC), a developer of vaccines for infectious diseases, announced on Thursday that they are collabor...
20 August 2026 - Clinical stage biotechnology company Annexin Pharmaceuticals AB (FN STO:ANNX) said on Thursday that the World Health Organization (WHO) has selected vanexin as the proposed International Nonproprietary Name (INN) for its drug candida...
20 August 2026 - US-based biotechnology company Pillar Biosciences Inc announced on Wednesday a collaboration with LC-SCRUM-Asia, a lung cancer screening project, and LSI Medience Corporation, a Japanese subsidiary of PHC Holdings Corporation, to sup...
20 August 2026 - Pharmaceutical company Vascarta Inc announced on Wednesday that a second proof of concept phase I clinical study of VAS-101 (Vasceptor; topical curcumin gel) in sickle cell disease (SCD) is underway.Conducted at the National Institut...
20 August 2026 - Amplitude Therapeutics, a biotechnology company developing trans-amplifying RNA (taRNA) medicines and vaccines, announced on Wednesday a strategic research collaboration and licensing agreement with Eli Lilly and Company (NYSE:LLY) t...
19 August 2026 - Swedish biopharma company BioArctic AB (STO: BIOA-B), which develops treatments for neurodegenerative diseases, said on Wednesday it has entered a research collaboration with Mesenkia Therapeutics to explore an antibody-based approac...
19 August 2026 - Sectra (STO: SECT B), a medical imaging IT and cybersecurity company, announced on Wednesday that it will provide its cloud-based Education Portal to Loyalist College in Ontario, Canada, giving students access to anonymized diagnosti...